Vimarsana
Biggest News Aggregation in the World

Degenerative Diseases Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Degenerative Diseases Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Degenerative Diseases Program Today - Breaking & Trending Today

Alzheimer's disease: Could HIV drugs help fight this condition? - Vimarsana News

Alzheimer's disease: Could HIV drugs help fight this condition?

A recent study suggests that a type of drugs commonly used to treat HIV are also associated with a lower incidence of Alzheimer's disease in those who take them.

With the help of naked mole rats, Xiao Tian seeks to expose and explain the epigenetic drivers of aging - Vimarsana News

With the help of naked mole rats, Xiao Tian seeks to expose and explain the epigenetic drivers of aging

Xiao Tian, Ph.D., who recently joined Sanford Burnham Prebys as an assistant professor in the Degenerative Diseases Program, focuses on epigenomic changes and d

Timothy Huang receives $2.8 million to continue research on Alzheimer's disease - Vimarsana News

Timothy Huang receives $2.8 million to continue research on Alzheimer's disease

Timothy Huang, Ph.D., has been awarded $2.8 million by the National Institute on Aging (NIA) to continue his work on Alzheimer's disease.

Indiana researchers get $12 million for hemophilia research - Vimarsana News

Indiana researchers get $12 million for hemophilia research

INDIANAPOLIS (WTWO/WAWV) - An Indiana University researcher will lead a multi-institute effort geared toward improving hemophilia therapies with the h...

Researchers secure $12 million grant to develop improved therapies for hemophilia - Vimarsana News

Researchers secure $12 million grant to develop improved therapies for hemophilia

An Indiana University School of Medicine researcher will lead a multi-institute effort toward improved therapies for hemophilia with help from a $12 million grant from the National Heart Lung and Blood Institute.